# T-Control® Safety for Cytostatics Management

> **NCT06678633** · NA · NOT_YET_RECRUITING · sponsor: **Rethink Medical SL** · enrollment: 16 (estimated)

## Conditions studied

- Non-muscle-invasive Bladder Cancer

## Interventions

- **DEVICE:** T-Control® (experimental)
- **DEVICE:** Folysil® (control)

## Key facts

- **NCT ID:** NCT06678633
- **Lead sponsor:** Rethink Medical SL
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-11
- **Primary completion:** 2026-11
- **Final completion:** 2027-02
- **Target enrollment:** 16 (ESTIMATED)
- **Last updated:** 2025-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06678633

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06678633, "T-Control® Safety for Cytostatics Management". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06678633. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*